Ion Beam Applications SA
Research Ion Beam Applications SA (IBAB) on Bullrun: market cap EUR 446.80M, P/E 36.6, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIBAB
- ExchangeBR
- CountryBelgium
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 446.80M
- P/E36.6
- Dividend yield1.5%
- Financial periodFY2025
- RevenueEUR 620.18M
- Revenue growth24.5%
- Net incomeEUR 12.73M
- Free cash flow-EUR 34.99M
- Gross margin32.2%
Valuation Snapshot
latest market cap is EUR 446.80M; P/E is 36.6; dividend yield is 1.5%.
Peer valuation comparison
Latest P/E is 36.55x versus a Healthcare sector median of 24.46x (49.4% above).
Latest dividend yield is 1.48% versus a Healthcare sector median of 2.11% (29.9% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 620.18M | EUR 12.73M | -EUR 34.99M | 32.2% | 0.43 | EUR 64.69M | EUR 55.34M | EUR 127.17M |
| FY2024 | EUR 498.16M | EUR 9.25M | -EUR 18.01M | 33.3% | 0.31 | EUR 72.17M | EUR 43.69M | EUR 110.92M |
| FY2023 | EUR 466.67M | -EUR 9.11M | -EUR 32.08M | 28.8% | -0.31 | EUR 109.31M | EUR 41.58M | EUR 106.21M |
| FY2022 | EUR 361.27M | EUR 6.06M | EUR 14.38M | 35.1% | 0.2 | EUR 158.37M | EUR 40.87M | EUR 115.95M |
| FY2021 | EUR 312.96M | EUR 3.88M | EUR 82.18M | 34.4% | 0.13 | EUR 199.27M | EUR 68.98M | EUR 125.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 446.80M | 36.6 | 1.6% | 0.25 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.25 EUR, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.24 EUR |
| FY2024 | 0.17 EUR |
| FY2023 | 0.21 EUR |
| FY2022 | 0.19 EUR |
| FY2021 | 0.2 EUR |
About Ion Beam Applications SA
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ion Beam Applications SA's market cap?
Ion Beam Applications SA's market capitalization is EUR 446.80M.
What is Ion Beam Applications SA's P/E ratio?
Ion Beam Applications SA's price-to-earnings (P/E) ratio is 36.6.
Does Ion Beam Applications SA pay a dividend?
Ion Beam Applications SA has a dividend yield of 1.5%.
What does Ion Beam Applications SA do?
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate.